Syneos Health, Inc. (SYNH) Prices 6M Share Secondary Offering at $61.90/Sh
Get Alerts SYNH Hot Sheet
Join SI Premium – FREE
Syneos Health, Inc. (NASDAQ: SYNH) today announced the pricing of the previously announced underwritten secondary offering by affiliates of Thomas H. Lee Partners, L.P. and Advent International Corporation of an aggregate of 6,000,000 shares of the Company’s common stock (the “Offering”) at a price to the public of $61.90 per share. Syneos Health is not selling any shares and will not receive any proceeds from the proposed sale of the shares by the selling stockholders in the Offering. The Offering is expected to close on December 3, 2020, subject to customary closing conditions.
Goldman Sachs & Co. LLC and BofA Securities are acting as the underwriters of the Offering.
An automatic shelf registration statement (including a prospectus) relating to the Offering was filed with the Securities and Exchange Commission (“SEC”) on November 27, 2018 and became effective upon filing. Before you invest, you should read the registration statement, prospectus, prospectus supplement and other documents Syneos Health has made available with the SEC for information about Syneos Health and the Offering.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Coinbase (COIN) CEO Armstrong on X: Great progress on the SEC case - and huge win for self-custodial wallets
- Praxis Precision Medicines (PRAX) Announces Proposed Share Offering
- AMC Entertainment (AMC) enters into an equity distribution agreement
Create E-mail Alert Related Categories
Corporate News, Equity OfferingsRelated Entities
Goldman Sachs, Thomas H. Lee Partners, Earnings, Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!